Literature DB >> 3964695

Interactions of antibiotics of the iturin group with human erythrocytes.

C Latoud, F Peypoux, G Michel, R Genet, J L Morgat.   

Abstract

The peptidolipid antibiotics, iturin A and bacillomycin L have a disrupting effect on erythrocyte membrane leading to a simultaneous release of K+ ions and hemoglobin. The formation of ghosts is accompanied by a partial solubilisation of lipid components. Binding experiments with radioactive antibiotics show that about 7 X 10(7) molecules of iturin A and 4 X 10(7) molecules of bacillomycin L are bound to one erythrocyte at the concentration giving 100% hemolysis. This concentration is reduced by about 20% after treatment of erythrocytes by phospholipase A2. Scatchard plots show that the affinity for erythrocyte membrane is higher with bacillomycin L than with iturin A. This difference is probably correlated to the differences in their peptide moieties. The substitution of tyrosyl residue leads to a ten-fold increase of the concentrations giving 100% hemolysis, probably due to a low distribution coefficient of derivatives between the membrane and the solvent. This result and the humped Scatchard curves obtained with both antibiotics may be related to the self-association of the compounds in aqueous solutions.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3964695     DOI: 10.1016/0005-2736(86)90144-6

Source DB:  PubMed          Journal:  Biochim Biophys Acta        ISSN: 0006-3002


  11 in total

1.  Susceptibility of Candida albicans Isolated from Blood to Wickerhamomyces anomalous Mycocins.

Authors:  Ana Paula Paris; Cristiane Persel; Cleber Fernando Serafin; Rita de Cássia Garcia Simão; Rinaldo Ferreira Gandra
Journal:  Curr Microbiol       Date:  2016-09-16       Impact factor: 2.188

Review 2.  Antifungal peptides: novel therapeutic compounds against emerging pathogens.

Authors:  A J De Lucca; T J Walsh
Journal:  Antimicrob Agents Chemother       Date:  1999-01       Impact factor: 5.191

Review 3.  Sequential and Structural Aspects of Antifungal Peptides from Animals, Bacteria and Fungi Based on Bioinformatics Tools.

Authors:  Karuna Singh; Jyoti Rani
Journal:  Probiotics Antimicrob Proteins       Date:  2016-06       Impact factor: 4.609

4.  Chemoenzymatic Synthesis, Nanotization, and Anti-Aspergillus Activity of Optically Enriched Fluconazole Analogues.

Authors:  Shashwat Malhotra; Seema Singh; Neha Rana; Shilpi Tomar; Priyanka Bhatnagar; Mohit Gupta; Suraj K Singh; Brajendra K Singh; Anil K Chhillar; Ashok K Prasad; Christophe Len; Pradeep Kumar; Kailash C Gupta; Anjani J Varma; Ramesh C Kuhad; Gainda L Sharma; Virinder S Parmar; Nigel G J Richards
Journal:  Antimicrob Agents Chemother       Date:  2017-07-25       Impact factor: 5.191

5.  Peptide-based Antifungal Therapies against Emerging Infections.

Authors:  A Matejuk; Q Leng; M D Begum; M C Woodle; P Scaria; S-T Chou; A J Mixson
Journal:  Drugs Future       Date:  2010-03       Impact factor: 0.148

6.  Inhibition of some mycotoxigenic fungi by iturin A, a peptidolipid produced by Bacillus subtilis.

Authors:  M A Klich; A R Lax; J M Bland
Journal:  Mycopathologia       Date:  1991-11       Impact factor: 2.574

7.  Iturin A: a potential new fungicide for stored grains.

Authors:  M A Klich; K S Arthur; A R Lax; J M Bland
Journal:  Mycopathologia       Date:  1994-08       Impact factor: 2.574

8.  Biochemical characterization of an anti-Candida factor produced by Enterococcus faecalis.

Authors:  Raeesh M Shekh; Utpal Roy
Journal:  BMC Microbiol       Date:  2012-07-04       Impact factor: 3.605

Review 9.  Antifungal Peptides as Therapeutic Agents.

Authors:  Miguel Fernández de Ullivarri; Sara Arbulu; Enriqueta Garcia-Gutierrez; Paul D Cotter
Journal:  Front Cell Infect Microbiol       Date:  2020-03-17       Impact factor: 5.293

10.  Hydroxyethylamine Based Phthalimides as New Class of Plasmepsin Hits: Design, Synthesis and Antimalarial Evaluation.

Authors:  Anil K Singh; Sumit Rathore; Yan Tang; Nathan E Goldfarb; Ben M Dunn; Vinoth Rajendran; Prahlad C Ghosh; Neelu Singh; N Latha; Brajendra K Singh; Manmeet Rawat; Brijesh Rathi
Journal:  PLoS One       Date:  2015-10-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.